Article
I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
Liver international : official journal of the International Association for the Study of the Liver - 1 Dec 2015
Park Jin-Ho, Cho BeLong, Kwon Hyuktae, Prilutsky Daria, Yun Jae Moon, Choi Ho Chun, Hwang Kyu-Baek, Lee In-Hee, Kim Jong-Il, Kong Sek Won
Abstract excerpt
BACKGROUND & AIMS: The I148M variant because of the substitution of C to G in PNPLA3 (rs738409) is associated with the increased risk of nonalcoholic fatty liver disease (NAFLD). In liver, I148M variant reduces hydrolytic function of PNPLA3, which results in hepatic steatosis; however, its association with the other clinical phenotype such as adiposity and metabolic diseases is not well established. METHODS: To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
